- Home
- TNGX vs GROY Comparison
TNGX vs GROY Comparison
Compare TNGX & GROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- GROY
- Stock Information
- Founded
- TNGX 2014
- GROY 2020
- Country
- TNGX United States
- GROY Canada
- Employees
- TNGX N/A
- GROY N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- GROY
- Sector
- TNGX Health Care
- GROY
- Exchange
- TNGX Nasdaq
- GROY Nasdaq
- Market Cap
- TNGX 351.2M
- GROY 322.2M
- IPO Year
- TNGX N/A
- GROY 2021
- Fundamental
- Price
- TNGX $6.01
- GROY $2.46
- Analyst Decision
- TNGX Strong Buy
- GROY Strong Buy
- Analyst Count
- TNGX 6
- GROY 3
- Target Price
- TNGX $12.20
- GROY $3.67
- AVG Volume (30 Days)
- TNGX 2.7M
- GROY 1.9M
- Earning Date
- TNGX 08-06-2025
- GROY 08-12-2025
- Dividend Yield
- TNGX N/A
- GROY N/A
- EPS Growth
- TNGX N/A
- GROY N/A
- EPS
- TNGX N/A
- GROY N/A
- Revenue
- TNGX $40,990,000.00
- GROY $10,347,000.00
- Revenue This Year
- TNGX N/A
- GROY $88.55
- Revenue Next Year
- TNGX N/A
- GROY $52.87
- P/E Ratio
- TNGX N/A
- GROY N/A
- Revenue Growth
- TNGX 10.09
- GROY 99.94
- 52 Week Low
- TNGX $1.03
- GROY $1.16
- 52 Week High
- TNGX $12.02
- GROY $2.49
- Technical
- Relative Strength Index (RSI)
- TNGX 76.36
- GROY 65.74
- Support Level
- TNGX $5.34
- GROY $2.23
- Resistance Level
- TNGX $6.40
- GROY $2.41
- Average True Range (ATR)
- TNGX 0.50
- GROY 0.11
- MACD
- TNGX -0.02
- GROY -0.01
- Stochastic Oscillator
- TNGX 84.08
- GROY 70.86
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About GROY Gold Royalty Corp.
Gold Royalty Corp is a precious metals-focused royalty and mineral streaming company. The company offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests. The company derives maximum revenue from Canada.